How soon after discharge from Labor and Delivery (L&D) should a female with gestational hypertension follow up with her Obstetrician (OB)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 3, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Follow-up Timing for Women with Gestational Hypertension After Labor and Delivery Discharge

Women with gestational hypertension should be reviewed within 1 week after discharge from the hospital if still requiring antihypertensive medications, and all women with gestational hypertension should have a follow-up visit within 7-10 days postpartum regardless of medication status. 1, 2

Immediate Postpartum Monitoring

  • Blood pressure should be monitored at least 4-6 hourly during the day for at least 3 days postpartum, as preeclampsia may develop de novo intra- or early postpartum 1
  • Women with gestational hypertension should not be discharged early (before 24 hours) to ensure adequate monitoring of vital signs 1
  • All women should stay in the healthcare facility for at least 24 hours after delivery or until vital signs are normal 1

Discharge Planning and Follow-up Schedule

For Women on Antihypertensive Medications:

  • Women still requiring antihypertensive medications at discharge should be reviewed within 1 week 1
  • Antihypertensive medications should be continued after delivery and tapered slowly only after days 3-6 postpartum unless BP becomes low (<110/70 mm Hg) 1

For All Women with Gestational Hypertension:

  • Initial follow-up should occur within 7-10 days postpartum 2
  • Additional check-ups should be scheduled at 7-14 days and at 6 weeks postpartum 1
  • All women should be reviewed at 3 months postpartum by which time BP, urinalysis, and all laboratory tests should have normalized 1

Risk Stratification for Follow-up

  • Women with more severe disease features require closer monitoring 2
  • Factors associated with higher risk and need for closer follow-up include:
    • Preeclampsia (versus gestational hypertension alone) 2
    • Severe hypertension during hospitalization 2
    • Magnesium sulfate use during hospitalization 2
    • Cesarean delivery 2

Monitoring Parameters at Follow-up Visits

  • Blood pressure measurement 1
  • Urinalysis to check for persistent proteinuria 1
  • Laboratory tests if abnormal before delivery (hemoglobin, platelets, creatinine, liver transaminases) 1
  • Assessment for depression, anxiety, or posttraumatic stress disorder symptoms 1

Important Considerations

  • Persistent abnormalities at 3 months require further investigation, including work-up for secondary causes of persistent severe hypertension or underlying renal disease 1
  • Women should be educated about the danger signs of preeclampsia after birth, including headaches, visual disturbances, nausea, vomiting, epigastric pain, and convulsions 1
  • Special attention should be paid to ensure follow-up in populations at higher risk for poor outcomes, as studies show non-Hispanic Black women have lower rates of postpartum follow-up despite higher rates of maternal morbidity and mortality 2

Long-term Follow-up

  • All women with gestational hypertension require lifelong follow-up because of their increased cardiovascular risk 1
  • Regular follow-up with a general practitioner to monitor BP and periodic measurement of fasting lipids and blood sugar is recommended 1
  • Women should be advised that they have approximately a 4% risk for developing preeclampsia and a 25% risk for gestational hypertension in a future pregnancy 1

Following this follow-up schedule is crucial for preventing complications, as hypertensive disorders can worsen or initially present after delivery and account for up to 44% of pregnancy-related deaths in the first six days postpartum 3.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Hypertensive Disorders of Pregnancy.

American family physician, 2024

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.